ESErich-Franz Solomayer

Erich-Franz Solomayer

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Erich-Franz Solomayer has a total of 330 co-authors. Here are the top co-authors by number of shared publications:

  • Jens-Uwe Blohmer

    Klinik für Gynäkologie mit Brustzentrum, Charité-Universitätsmedizin Berlin, Berlin, Germany

    15 shared publications
  • Nicolai Maass

    Klinik für Gynäkologie und Geburtshilfe, Universitätsklinikum Schleswig-Holstein, Campus Kiel, Kiel, Germany

    15 shared publications
  • Tanja Fehm

    Klinik für Frauenheilkunde und Geburtshilfe, Universitätsklinikum Düsseldorf, Düsseldorf, Deutschland

    15 shared publications
  • Volkmar Müller

    Klinik und Poliklinik für Gynäkologie, Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany

    15 shared publications
  • Wolfgang Janni

    Klinik für Frauenheilkunde und Geburtshilfe, Universitätsklinikum Ulm, Ulm, Germany

    15 shared publications
  • Achim Rody

    Klinik für Gynäkologie und Geburtshilfe, Universitätsklinikum Schleswig-Holstein, Campus Lübeck, Lübeck, Germany

    14 shared publications

Latest Publications

  • Open Access

    Supplementary Data from Cervical Cancer–Instructed Stromal Fibroblasts Enhance IL23 Expression in Dendritic Cells to Support Expansion of Th17 Cells

    by Barbara Walch-Rückheim, Russalina Ströder, Laura Theobald, Jennifer Pahne-Zeppenfeld, Subramanya Hegde, Yoo-Jin Kim, Rainer Maria Bohle, Ingolf Juhasz-Böss, Erich-Franz Solomayer, Sigrun Smola

    Supplementary data includes Supplementary Materials and Methods, Supplementary Figures 1-6 with Legends and Supplementary table S1. Supplementary figures showing 1) characterization of isolated normal exocervical fibroblasts and 2) primary freshly isolated fibroblasts from cervical cancer outgrowth cultures, 3) isotype control stainings, 4) enhanced IL-23 but reduced IL-12 expression in cervical cancer-instructed mDC/NECF co-cultures, and elevated levels of IL23p19 and IL-12p40 but reduced IL-12p35 in cervical cancer-instructed mDC after co-cultivation with fibroblasts, 5) analysis of IL-6Ra expression of NECF and rhIL-6-induced IL-1b - and C/EBPb -expression in NECF, and 6) supernatants of cervical cancer-instructed mDC-NECF co-cultures only slightly induce Th17 but not Th1 differentiation, and neutralization of CCL20 in supernatants of fibroblasts did not affect IL-23 expression of DC and subsequent Th17 expansion. Supplementary table S1 shows the expression of maturation markers of LPS- and TNF-α-matured cervical cancer-instructed DC before and after co-cultures.

  • Open Access

    Data from Cervical Cancer–Instructed Stromal Fibroblasts Enhance IL23 Expression in Dendritic Cells to Support Expansion of Th17 Cells

    by Barbara Walch-Rückheim, Russalina Ströder, Laura Theobald, Jennifer Pahne-Zeppenfeld, Subramanya Hegde, Yoo-Jin Kim, Rainer Maria Bohle, Ingolf Juhasz-Böss, Erich-Franz Solomayer, Sigrun Smola

    Persistent infection with high-risk human papillomavirus (HPV) is a prerequisite for the development of cervical cancer. HPV-transformed cells actively instruct their microenvironment, promoting chronic inflammation and cancer progression. We previously demonstrated that cervical cancer cells contribute to Th17 cell recruitment, a cell type with protumorigenic properties. In this study, we analyzed the expression of the Th17-promoting cytokine IL23 in the cervical cancer micromilieu and found CD83+ mature dendritic cells (mDC) coexpressing IL23 in the stroma of cervical squamous cell carcinomas in situ. This expression of IL23 correlated with stromal Th17 cells, advanced tumor stage, lymph node metastasis, and cervical cancer recurrence. Cocultures of cervical cancer–instructed mDCs and cervical fibroblasts led to potent protumorigenic expansion of Th17 cells in vitro but failed to induce antitumor Th1 differentiation. Correspondingly, cervical cancer–instructed fibroblasts increased IL23 production in cocultured cervical cancer–instructed mDCs, which mediated subsequent Th17 cell expansion. In contrast, production of the Th1-polarizing cytokine IL12 in the cancer-instructed mDCs was strongly reduced. This differential IL23 and IL12 regulation was the consequence of an increased expression of the IL23 subunits IL23p19 and IL12p40 but decreased expression of the IL12 subunit IL12p35 in cervical cancer–instructed mDCs. Cervical cancer cell–derived IL6 directly suppressed IL12p35 in mDCs but indirectly induced IL23 expression in fibroblast-primed mDCs via CAAT/enhancer-binding protein β (C/EBPβ)–dependent induction of IL1β. In summary, our study defines a mechanism by which the cervical cancer micromilieu supports IL23-mediated Th17 expansion associated with cancer progression.Significance:Cervical cancer cells differentially regulate IL23 and IL12 in DC fibroblast cocultures in an IL6/C/EBPβ/IL1β-dependent manner, thereby supporting the expansion of Th17 cells during cancer progression.

  • AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2026

    by Marc Thill, Volkmar Müller, Tanja Fehm, Ute-Susann Albert, Maggie Banys-Paluchowski, Rupert Bartsch, Ingo Bauerfeind, Vesna Bjelic-Radisic, Jens Blohmer, Peter Dall, et al.

    The Breast Committee of the Arbeitsgemeinschaft Gynäkologische Onkologie (German Gynecological Oncology Group, AGO) presents the 2026 update of the evidence-based recommendations for the diagnosis and treatment of patients with locally advanced and metastatic breast cancer.


  • Open Access

    AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2026

    by Tjoung-Won Park-Simon, Volkmar Müller, Ute-Susann Albert, Maggie Banys-Paluchowski, Rupert Bartsch, Ingo Bauerfeind, Vesna Bjelic-Radisic, Jens-Uwe Blohmer, Peter Dall, Nina Ditsch, et al.

    Optimal management of breast cancer requires a multidisciplinary approach. The interdisciplinary AGO Breast Committee annually issues updated,


  • Open Access

    Multi-Protein Profiling Reveals High Nuclear KFL-4 Expression as a Predictor of Poor Overall Survival in Breast Cancer: A Retrospective Cohort Study

    by Mariz Kasoha, Bashar Haj Hamoud, Rainer M. Bohle, Barbara Linxweiler, Raphaela Bosch, Gilbert Georg Klamminger, Gilda Schmidt, Erich-Franz Solomayer, Meletios P. Nigdelis

    Following the establishment of the four molecular subtypes of breast cancer, additional biomarkers are required to further refine prognostication and patient stratification. Krüppel-like factors (KLFs), components of Wnt signaling, estrogen receptor beta (ERβ) isoforms, cyclin D1, and E-cadherin have been implicated in epithelial–mesenchymal transition, tumor proliferation, and disease progression. In this monocentric retrospective cohort study, tissue microarrays from 153 patients with histologically confirmed breast cancer were analyzed by immunohistochemistry to assess the expression of cytoplasmic Dkk1, β-catenin, and E-cadherin, as well as nuclear cyclin D1, KLF-4, KLF-5, and ERβ isoforms, using the Remmele and Stegner immunoreactive score. Associations between protein expression patterns with clinicopathological characteristics and survival outcomes using univariable and multivariable Cox regression analyses were examined. High cytoplasmic E-cadherin expression was associated with improved overall survival [hazard ratio (HR) 0.37, 95% confidence interval (95% CI) 0.18–0.77, p = 0.008], whereas high nuclear expression of KLF-4 (HR 2.63, 95% CI 1.32–5.22, p = 0.006) and KLF-5 (HR 2.16, 95% CI 1.01–4.65, p = 0.048) was associated with reduced overall survival. High ERβ1 expression showed a marginally protective association with the development of metastases (log-rank test p = 0.045). Importantly, nuclear KLF-4 expression remained independently associated with adverse overall survival after adjustment for tumor stage, lymph node status, molecular subtype, and other molecular markers (adjusted HR 4.09, 95% CI 1.93–8.67, p < 0.001). These findings identify nuclear KLF-4 as an adverse prognostic marker in breast cancer and support its potential relevance for molecular patient stratification.

  • Open Access

    Relationship Between Prostaglandin and Interleukin Concentrations in Seminal Fluid and Their Influence on the Rate of Fertilization in Men Undergoing ICSI

    by Houda Amor, Fatina W. Dahadhah, Peter Michael Jankowski, Rami Al Nasser, Lisa Jung, Ingolf Juhasz-Böss, Erich Franz Solomayer, Mohamad Eid Hammadeh

    Sperm count, motility, and morphology are semen parameters that directly affect male fertility. The presence of cytokines in seminal plasma negatively or positively influences these parameters. Interleukins and prostaglandins are proinflammatory cytokines present in human seminal plasma and play crucial roles in fertilization, in general and after intracytoplasmic sperm injection (ICSI) procedures. This study aimed to investigate the possible influence of interleukins IL-17 and IL-18, and prostaglandins PGE2 and PGF2α on male infertility. Semen samples were collected from 58 males who underwent the ICSI procedure. An enzyme-linked immunosorbent assay (ELISA) was used to determine the levels of IL-17, IL-18, PGE2, and PGF2α, and these concentrations were then correlated with semen parameters and the rate of fertilization. Furthermore, the chromatin integrity of the sperm was evaluated with an Acridine Orange (AO) assay. The results showed an inversely proportional relationship between the AO binding intensity and fertilization rate (r = −0.394; p ≤ 0.002). Furthermore, a negative correlation was observed between the IL-18 concentration and positive AO (p ≤ 0.021). Moreover, the IL-18 concentration was positively correlated with the fertilization rate (p ≤ 0.05). In contrast, IL-17 did not significantly correlate with any semen parameters or with the fertilization rate. Seminal PGE2 levels were significantly correlated with embryo cleavage at 72 h (p ≤ 0.05). To conclude, this study revealed that denaturation of sperm nuclear deoxyribonucleic acid (DNA) contributes to low fertilization rates. In addition, this study proposed a potential role for IL-18 in fertilization. PGE2 likely influences embryo development, but further studies are needed to examine the impact of seminal PGE2 on the oocyte to fully elucidate its contribution to this complex biological process.


  • Open Access

    Evaluation of Tumor Budding and Poorly Defined Clusters as Histological Biomarkers in Squamous Cell Carcinomas of the Vulva

    by Gilbert Georg Klamminger, Annick Bitterlich, Bashar Haj Hamoud, Erich-Franz Solomayer, Martin Ertz, Laura Schnöder, Bernd Holleczek, Walburgis Brenner, Annette Hasenburg, Mathias Wagner, et al.

    Background/Objectives: Several histopathological risk factors have been examined in vulvar cancer (VC) so far. However, the prognostic relevance of morphological biomarkers such as tumor budding (TB) and poorly defined clusters (PDCs) remains to be determined. Material and Methods: We histologically analyzed the formation of peritumoral and intratumoral TB and PDCs in a cohort of 157 patients with VC. We assessed their association with clinico-pathological features and evaluated their prognostic impact in terms of the risk of local recurrence and occurrence of metastasis (Fisher’s exact test) as well as overall survival (Log-rank test). Results: We determined a distinct prognostic relevance of peritumoral TB with regard to occurrence of metastasis (Fisher’s exact test; p = 0.0415) as well as a significant reduced risk of local recurrence in the group with absent intratumoral TB (Fisher’s exact test; p = 0.0004). Furthermore, we showed that patients without peritumoral budding formation had a significant superior prognosis in terms of overall survival (p = 0.0366, x2 = 4.370). Conclusions: This study shows that several new histomorphological biomarkers may serve useful in predicting the clinical course of patients with VC, identifying patients at a lower risk of developing metastases/local recurrence as well as improved overall survival.


  • Open Access

    Machine Learning Based Assessment of Inguinal Lymph Node Metastasis in Patients with Squamous Cell Carcinoma of the Vulva

    by Gilbert Georg Klamminger, Meletios P. Nigdelis, Annick Bitterlich, Bashar Haj Hamoud, Erich-Franz Solomayer, Annette Hasenburg, Mathias Wagner

    Background/Objectives: Despite great efforts from both clinical and pathological sides to address the extent of metastatic inguinal lymph node involvement in patients with vulvar cancer, current research attempts are still mostly aimed at identifying new imaging parameters or superior tissue diagnostic workflows rather than alternative ways of statistical data analysis. In the present study, we therefore establish a supervised machine learning algorithm to predict groin metastasis in patients with squamous cell carcinoma of the vulva (VSCC) based on classical histomorphological features. Methods: In total, 157 patients with VSCC were included in this retrospective study. After initial exploration of valuable clinicopathological predictor variables by means of Spearman correlation, a decision tree was trained and internally validated (5-fold cross-validation) using a training data set (n = 126) and afterwards externally validated employing a holdout validation data set (n = 31) using standard metrices such sensitivity, positive predictive value, and AUROC curve. Results: Our established classifier can predict inguinal lymph node status with an internal accuracy of 79.4% (AUROC value = 0.64). Reaching similar performances and an overall accuracy of 83.9% on an unknown data input (external validation set), our classifier demonstrates robustness. Conclusions: The presented results suggest that machine learning can predict groin lymph node status in VSCC based on histological findings of the primary tumor. Such research attempts may be useful in the future for an additional assessment of inguinal lymph nodes, aiming to maximize oncological safety when targeting the most accurate diagnosis of lymph node involvement.

  • Open Access

    AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2025

    by Tjoung-Won Park-Simon, Volkmar Müller, Ute-Susann Albert, Maggie Banys-Paluchowski, Rupert Bartsch, Ingo Bauerfeind, Vesna Bjelic-Radisic, Jens-Uwe Blohmer, Wilfried Budach, Peter Dall, et al.

    The Breast Committee of the Arbeitsgemeinschaft Gynäkologische Onkologie (German Gynecological Oncology Group, AGO) presents the 2025 update of the evidence-based recommendations for the diagnosis and treatment of patients with early breast cancer.


  • AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2025

    by Marc Thill, Wolfgang Janni, Ute-Susann Albert, Maggie Banys-Paluchowski, Rupert Bartsch, Ingo Bauerfeind, Vesna Bjelic-Radisic, Jens Blohmer, Wilfried Budach, Peter Dall, et al.

    The Breast Committee of the Arbeitsgemeinschaft Gynäkologische Onkologie (AGO; German Gynecological Oncology Group) presents the 2025 update of the evidence-based recommendations for the diagnosis and treatment of patients with locally advanced and metastatic breast cancer (mBC).